SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
Description
The COVID-19 pandemic and SARS-CoV-2 variants have dramatically illustrated the need for a better understanding of antigen (epitope)-antibody (paratope) interactions. To gain insight into the immunogenic characteristics of epitopic sites (ES), we
